Related Experiment Video

Updated: Oct 16, 2025

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
05:06

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

786

Virulence Potential and Treatment Options of Multidrug-Resistant (MDR) Acinetobacter baumannii

Sunil Kumar1, Razique Anwer2, Arezki Azzi3

  • 1Department of Biotechnology, Maharishi Markandeshwar (Deemed to Be University), Mullana, Ambala 133207, India.

Microorganisms
|October 23, 2021
PubMed

Insights

Acinetobacter baumannii causes severe hospital infections. Understanding its virulence factors is crucial for developing new treatments against multidrug-resistant strains.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Acinetobacter baumannii is a significant cause of hospital-acquired infections, leading to high morbidity and mortality.
  • It causes severe conditions like ventilator-associated pneumonia (VAP), meningitis, bacteremia, and urinary tract infections (UTI).
  • The World Health Organization designated A. baumannii as a priority-1 pathogen due to its increasing prevalence and resistance.

Purpose of the Study:

  • To review recent discoveries on Acinetobacter baumannii virulence factors.
  • To highlight the need for novel therapeutic agents against multidrug-resistant strains.
  • To summarize effective antimicrobial strategies for managing A. baumannii infections.

Main Methods:

  • Literature review of scientific publications on A. baumannii virulence factors.
  • Analysis of the roles of outer membrane proteins, efflux pumps, biofilm, penicillin-binding proteins, and siderophores.
  • Examination of current and emerging antimicrobial agents for treatment.

Main Results:

  • A. baumannii possesses diverse virulence factors contributing to its pathogenicity.
  • Multidrug resistance limits the effectiveness of current antibiotics like carbapenems, tigecycline, and colistin.
  • Understanding these factors is key to developing new therapeutic approaches.

Conclusions:

  • Targeting A. baumannii virulence factors offers a promising strategy for novel therapies.
  • Effective management requires a comprehensive understanding of bacterial resistance mechanisms.
  • Further research into alternative treatments is essential to combat A. baumannii infections.
Keywords:
Acinetobacter baumanniiGram-negative bacteriaanimal modelsantibiotic therapymechanism of actionmultidrug resistancevirulence factors

More Related Videos

Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization07:41

Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization

Published on: August 4, 2023

3.8K
In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging09:29

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

Published on: April 28, 2017

9.5K

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
73
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
384
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
499
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
137
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
428
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
267